Is MTCR or JEPQ a better dividend investment in 2026?

MTCR currently yields 344.00% with a 5% 5-year dividend growth rate. JEPQ yields 11.10% with 5% growth. The better choice depends on your goal: MTCR offers higher current income.

What is the dividend yield difference between MTCR and JEPQ?

MTCR has a forward dividend yield of 344.00% ($2.00/share annually). JEPQ yields 11.10% ($6.16/share annually). The yield gap is 332.90 percentage points.

Home › Compare › MTCR vs JEPQ

MTCR vs JEPQ: Dividend Comparison 2026

MTCR yields 344.00% · JEPQ yields 11.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MTCR wins by $3877.89M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MTCR

● Live price

344.00%

Share price

$0.58

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$3877.94M

Annual income

$2,467,114,396.16

Full MTCR calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.10%

Share price

$55.52

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.8K

Annual income

$2,152.59

Full JEPQ calculator →

Portfolio growth — MTCR vs JEPQ

📍 MTCR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MTCR	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MTCR + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MTCR pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MTCR

Annual income on $10K today (after 15% tax)

$29,239.77/yr

After 10yr DRIP, annual income (after tax)

$2,097,047,236.74/yr

JEPQ

Annual income on $10K today (after 15% tax)

$943.83/yr

After 10yr DRIP, annual income (after tax)

$1,829.70/yr

At 15% tax rate, MTCR beats the other by $2,097,045,407.03/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MTCR + JEPQ for your $10,000?

MTCR: 50%JEPQ: 50%

100% JEPQ50/50100% MTCR

Portfolio after 10yr

$1938.99M

Annual income

$1,233,558,274.37/yr

Blended yield

63.62%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MTCR right now

MTCR

Analyst Ratings

Buy

Hold

Consensus: Hold

Altman Z

-5.6

Piotroski

2/9

JEPQ

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MTCR buys

JEPQ buys

No recent congressional trades found for MTCR or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMTCRJEPQ

Forward yield	344.00% ✓	11.10%
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$3877.94M ✓	$44.8K
Annual income after 10y	$2,467,114,396.16 ✓	$2,152.59
Total dividends collected	$3742.38M ✓	$16.3K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: MTCR vs JEPQ ($10,000, DRIP)

Year	MTCR Portfolio	MTCR Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$45,100	$34,399.72	$11,930	$1,110.39	+$33.2K → MTCR
2	$193,249	$144,992.35	$14,133	$1,224.34	+$179.1K → MTCR
3	$787,414	$580,637.11	$16,632	$1,340.46	+$770.8K → MTCR
4	$3,053,623	$2,211,090.63	$19,454	$1,457.97	+$3.03M → MTCR
5	$11,281,118	$8,013,740.98	$22,626	$1,576.08	+$11.26M → MTCR
6	$39,739,462	$27,668,665.51	$26,175	$1,694.09	+$39.71M → MTCR
7	$133,611,974	$91,090,750.49	$30,133	$1,811.32	+$133.58M → MTCR
8	$429,193,992	$286,229,179.66	$34,531	$1,927.17	+$429.16M → MTCR
9	$1,318,524,847	$859,287,275.81	$39,403	$2,041.08	+$1318.49M → MTCR
10	$3,877,935,983	$2,467,114,396.16	$44,787	$2,152.59	+$3877.89M → MTCR

MTCR vs JEPQ: Complete Analysis 2026

MTCR — Stock

Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Full MTCR Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this MTCR vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MTCR vs SCHD MTCR vs JEPI MTCR vs O MTCR vs KO MTCR vs MAIN MTCR vs XYLD MTCR vs QYLD MTCR vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.